Literature DB >> 7610771

Regenerative capacity of mdx mouse muscles after repeated applications of myo-necrotic bupivacaine.

Y Itagaki1, K Saida, K Iwamura.   

Abstract

We injected bupivacaine (BPVC), which produces muscle fiber necrosis, repeatedly into the soleus muscles of mdx mice, which represent a model of human Duchenne muscular dystrophy, over a 12-month period. Cytological and morphometric analysis revealed that the regenerative capacity of repeatedly BPVC-injected mdx muscles was almost equal to that of the saline-injected mdx muscles. At 9 months of age the endomysial collagen content of mdx muscles was 4.6 times that of control mice muscles, and was 7.2 times that of control mice muscle at 12 months. These results suggest that the regenerative capacity of the mdx muscle is quite large and that myo-necrosis induced by an extrinsic cause, such as BPVC, may not be an important factor in the disease progress. However, endomysial collagen, for which the mechanism of increase may be related to the defect of dystrophin, may play an important role in gradual decline of regeneration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7610771     DOI: 10.1007/BF00309633

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  32 in total

1.  Skeletal muscle regeneration after crush injury in dystrophic mdx mice: an autoradiographic study.

Authors:  M D Grounds; J K McGeachie
Journal:  Muscle Nerve       Date:  1992-05       Impact factor: 3.217

2.  Identification and change of collagen types in differentiating myoblasts and developing chick muscle.

Authors:  A J Bailey; G B Shellswell; V C Duance
Journal:  Nature       Date:  1979-03-01       Impact factor: 49.962

3.  Dystrophin is localized to the plasma membrane of human skeletal muscle fibers by electron-microscopic cytochemical study.

Authors:  S Carpenter; G Karpati; E Zubrzycka-Gaarn; D E Bulman; P N Ray; R G Worton
Journal:  Muscle Nerve       Date:  1990-05       Impact factor: 3.217

4.  Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles.

Authors:  J W Carnwath; D M Shotton
Journal:  J Neurol Sci       Date:  1987-08       Impact factor: 3.181

5.  Pathophysiology of muscle fiber necrosis induced by bupivacaine hydrochloride (Marcaine).

Authors:  I Nonaka; A Takagi; S Ishiura; H Nakase; H Sugita
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

6.  The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates.

Authors:  L F Torres; L W Duchen
Journal:  Brain       Date:  1987-04       Impact factor: 13.501

7.  Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide.

Authors:  K Arahata; S Ishiura; T Ishiguro; T Tsukahara; Y Suhara; C Eguchi; T Ishihara; I Nonaka; E Ozawa; H Sugita
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

8.  The mdx mouse skeletal muscle myopathy: II. Contractile properties.

Authors:  G R Coulton; N A Curtin; J E Morgan; T A Partridge
Journal:  Neuropathol Appl Neurobiol       Date:  1988 Jul-Aug       Impact factor: 8.090

9.  Congenital muscular dystrophy (CMD) - a collagen formative disease?

Authors:  A Fidzianska; H H Goebel; H G Lenard; C Heckmann
Journal:  J Neurol Sci       Date:  1982-07       Impact factor: 3.181

10.  Dystrophin colocalizes with beta-spectrin in distinct subsarcolemmal domains in mammalian skeletal muscle.

Authors:  G A Porter; G M Dmytrenko; J C Winkelmann; R J Bloch
Journal:  J Cell Biol       Date:  1992-06       Impact factor: 10.539

View more
  6 in total

1.  Muscle satellite cells from GRMD dystrophic dogs are not phenotypically distinguishable from wild type satellite cells in ex vivo culture.

Authors:  Zachary Berg; Lucas R Beffa; Daniel P Cook; D D W Cornelison
Journal:  Neuromuscul Disord       Date:  2011-01-28       Impact factor: 4.296

2.  Structural and functional roles of desmin in mouse skeletal muscle during passive deformation.

Authors:  Sameer B Shah; Jennifer Davis; Noah Weisleder; Ioanna Kostavassili; Andrew D McCulloch; Evelyn Ralston; Yassemi Capetanaki; Richard L Lieber
Journal:  Biophys J       Date:  2004-05       Impact factor: 4.033

3.  Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A.

Authors:  Ajay Kumar; Jenny Yamauchi; Tanya Girgenrath; Mahasweta Girgenrath
Journal:  Hum Mol Genet       Date:  2011-03-26       Impact factor: 6.150

4.  Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality.

Authors:  Zhi-Fang Li; G Diane Shelton; Eva Engvall
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

5.  Endothelial Lactate Controls Muscle Regeneration from Ischemia by Inducing M2-like Macrophage Polarization.

Authors:  Jing Zhang; Jonathan Muri; Gillian Fitzgerald; Tatiane Gorski; Roberto Gianni-Barrera; Evi Masschelein; Gommaar D'Hulst; Paola Gilardoni; Guillermo Turiel; Zheng Fan; TongTong Wang; Mélanie Planque; Peter Carmeliet; Luc Pellerin; Christian Wolfrum; Sarah-Maria Fendt; Andrea Banfi; Christian Stockmann; Inés Soro-Arnáiz; Manfred Kopf; Katrien De Bock
Journal:  Cell Metab       Date:  2020-06-02       Impact factor: 27.287

6.  Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice.

Authors:  Sajedah M Hindi; Jonghyun Shin; Yuji Ogura; Hong Li; Ashok Kumar
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.